Back to top
more

VanEck Vectors Biotech ETF: (BBH)

(Delayed Data from NASDAQ) As of Feb 15, 2019 03:58 PM ET

 Add to portfolio

$129.21 USD

129.21
7,186

+1.53 (1.20%)

Volume: 7,186

Zacks ETF Rank 2 - Buy   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 127.68
Open 128.11
Bid 128.67
Ask 137.13
Day Low-High 128.11-129.26
52wk Low-High 103.25-136.84
Volume 7,186
NAV (month end) 127.68
Premium (+)/Discount (-) (month end)+0.00

Zacks Premium Research for BBH

Zacks ETF Rank Buy 2
ETF Risk High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.55 (0.43%)
Issuer VAN ECK

Benchmark for BBH

MVIS US LISTED BIOTECH 25 INDEX

The MVIS US Listed Biotech 25 Index tracks the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Fund Summary for BBH

VANECK VECTORS BIOTECH ETF

The VanEck Vectors Biotech ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Biotech 25 Index.